Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 2Mycosis Fungoides 2Melanoma 2Lymphoma, T-Cell, Cutaneous 2Waldenstrom Macroglobulinemia 1Skin Neoplasms 1Sarcoma, Kaposi 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Hodgkin Disease 1AIDS-related Kaposi sarcoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 41fludarabine phosphate 33Cyclophosphamide 31Mycophenolic Acid 25Whole-Body Irradiation 22Cyclosporine 22Busulfan 21Tacrolimus 20Antilymphocyte Serum 17Methotrexate 16Filgrastim 14Etoposide 12Radiotherapy 11Psychiatric Rehabilitation 11Melphalan 11Methylprednisolone 10Flow Cytometry 10Therapeutics 9Polymerase Chain Reaction 8Gemcitabine 8Rituximab 7sargramostim 6Vorinostat 6Sirolimus 6Cord Blood Stem Cell Transplantation 6Transplantation 5Nivolumab 5Dexamethasone 5Calcium Dobesilate 5Bortezomib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Interleukin-12 × Dermatologic × Clear all
NCT00003210 2015-04-15

Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease

National Cancer Institute (NCI)

Phase 2 Completed
105 enrolled
DermatologicLymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡